Intellectual Property India Publishes Patent Application for 'Solid Pharmaceutical Formulations Of 6-(2-Chloro-6-Methylpyridin-4-Yl)-5-(-4-Fluorophenyl)-1,2,4- Triazin-3-Amine' Filed by Astrazeneca AB

MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202518028201 A) filed by Astrazeneca AB, Sodertalje, Sweden, on March 25, for 'solid pharmaceutical formulations of 6-(2-chloro-6-methylpyridin-4-yl)-5-(-4-fluorophenyl)-1,2,4- triazin-3-amine.'

Inventor(s) include Holmgren, Anders; Kyssa, Annika; Von Corswant, Christian; and Skantze, Urban.

The application for the patent was published on April 11, under issue no. 15/2025.

According to the abstract released by the Intellectual Property India: "Solid pharmaceutical formulations including AZD4635 are described. The solid formulations can include a polymeric stabilizer (e.g., a polyvinylpyrollidone), an ionic surfactant (e.g., sodium docusate), and a ...